New home pregnancy test put to the test: will it be easy and accurate?

NCT ID NCT07304531

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 09, 2026 · Updated 3 times

Summary

This study is checking if a new over-the-counter pregnancy test, called First To Know, works well when people use it at home. About 1705 women of different ages will take the test themselves and compare results to a standard blood test. The goal is to see if the test is accurate and simple enough for anyone to use without help.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
First To Know Pregnancy Test (a urine-based diagnostic device)
What this could lead to
If successful, this could lead to a reliable over-the-counter pregnancy test that people can use at home with confidence.
What could go wrong
This is an observational study evaluating an already FDA-cleared test for OTC use. The main risk is that real-world users may not use it as accurately as trained staff, which could affect performance.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

892 people

The number who actually took part.

Started

Oct 2025

Finished

May 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Female residents of the United States who elect to participate in the study.

Ages

14 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Females whose pregnancy status is unknown (e.g., have not used urine test at home) * Not menstruating at the time of the initial study visit * Must be willing to complete all study activities, provide all specimens/samples, and conduct all required testing * Willing to provide information regarding the diagnosis of pregnancy or details from their standard of care follow-up visit after initial visit * Sexually active * Not using contraceptives * English/Spanish speaking Exclusion Criteria: * Males * Females \<14 years of age * People with limited or no reading skills

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pregnancy detection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ERA Health Research

    Midland, Texas, 79707, United States

  • Matrix Clinical Research Los Angeles

    Los Angeles, California, 90057, United States